Stay updated on Pro-Netupitant Palonosetron IV Safety Clinical Trial
Sign up to get notified when there's something new on the Pro-Netupitant Palonosetron IV Safety Clinical Trial page.

Latest updates to the Pro-Netupitant Palonosetron IV Safety Clinical Trial page
- Check4 days agoChange DetectedThe record now presents details of the completed Phase 3 study of intravenous pro-netupitant/palonosetron for preventing chemotherapy-related nausea and vomiting, including its design, eligibility criteria, outcomes, locations, and publication. The former access-denied message and Home link are no longer shown.SummaryDifference78%

- Check11 days agoChange DetectedThe ClinicalTrials.gov footer revision changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA sitewide banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence,” and the displayed site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check39 days agoChange DetectedThe footer revision changed from v3.7.0 to v3.7.1. The page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check53 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the previous content and preventing access to the study record. This indicates an access issue rather than a change to the study data.SummaryDifference17%

- Check60 days agoChange DetectedRevision label updated from v3.6.6 to v3.7.0, indicating a new version of the study record. No study data or visible content changes accompany this update.SummaryDifference0.0%

Stay in the know with updates to Pro-Netupitant Palonosetron IV Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pro-Netupitant Palonosetron IV Safety Clinical Trial page.